JP Morgan Chase’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $405M | Sell |
755,791
-24,091
| -3% | -$13.5M | 0.02% | 515 |
|
|
2026
Q1 | $434M | Buy |
779,882
+106,654
| +16% | +$68.4M | 0.03% | 444 |
|
|
2025
Q4 | $455M | Sell |
673,228
-196,702
| -23% | -$134M | 0.03% | 417 |
|
|
2025
Q3 | $556M | Buy |
869,930
+326,348
| +60% | +$198M | 0.03% | 404 |
|
|
2025
Q2 | $292M | Buy |
543,582
+100,517
| +23% | +$48.1M | 0.02% | 567 |
|
|
2025
Q1 | $186M | Sell |
443,065
-94,373
| -18% | -$41M | 0.01% | 699 |
|
|
2024
Q4 | $222M | Sell |
537,438
-75,234
| -12% | -$33M | 0.02% | 633 |
|
|
2024
Q3 | $310M | Sell |
612,672
-155,783
| -20% | -$75.7M | 0.02% | 532 |
|
|
2024
Q2 | $374M | Sell |
768,455
-21,015
| -3% | -$10.6M | 0.03% | 434 |
|
|
2024
Q1 | $426M | Sell |
789,470
-83,221
| -10% | -$45.5M | 0.04% | 426 |
|
|
2023
Q4 | $484M | Buy |
872,691
+71,417
| +9% | +$33.5M | 0.05% | 362 |
|
|
2023
Q3 | $350M | Buy |
801,274
+65,760
| +9% | +$32.8M | 0.04% | 401 |
|
|
2023
Q2 | $369M | Buy |
735,514
+143,261
| +24% | +$68.7M | 0.04% | 385 |
|
|
2023
Q1 | $296M | Buy |
592,253
+63,857
| +12% | +$30.6M | 0.04% | 416 |
|
|
2022
Q4 | $216M | Buy |
528,396
+119,729
| +29% | +$46.5M | 0.03% | 498 |
|
|
2022
Q3 | $133M | Sell |
408,667
-24,195
| -6% | -$8.89M | 0.02% | 624 |
|
|
2022
Q2 | $152M | Buy |
432,862
+50,869
| +13% | +$20.7M | 0.02% | 599 |
|
|
2022
Q1 | $209M | Buy |
381,993
+125,091
| +49% | +$65.8M | 0.03% | 549 |
|
|
2021
Q4 | $169M | Buy |
256,902
+7,575
| +3% | +$4.76M | 0.02% | 634 |
|
|
2021
Q3 | $155M | Sell |
249,327
-40,286
| -14% | -$27.1M | 0.02% | 671 |
|
|
2021
Q2 | $183M | Sell |
289,613
-76,887
| -21% | -$42.5M | 0.02% | 638 |
|
|
2021
Q1 | $179M | Buy |
366,500
+29,038
| +9% | +$14.5M | 0.02% | 614 |
|
|
2020
Q4 | $169M | Sell |
337,462
-35,948
| -10% | -$16.1M | 0.02% | 582 |
|
|
2020
Q3 | $144M | Sell |
373,410
-45,840
| -11% | -$16.9M | 0.02% | 573 |
|
|
2020
Q2 | $138M | Buy |
419,250
+81,724
| +24% | +$23.7M | 0.03% | 544 |
|
|
2020
Q1 | $81.8M | Buy |
337,526
+266
| +0.1% | +$69.4K | 0.02% | 637 |
|
|
2019
Q4 | $88.1M | Sell |
337,260
-22,550
| -6% | -$5.94M | 0.02% | 720 |
|
|
2019
Q3 | $97.8M | Buy |
359,810
+19,291
| +6% | +$5.37M | 0.02% | 676 |
|
|
2019
Q2 | $92.6M | Buy |
340,519
+9,456
| +3% | +$2.33M | 0.02% | 700 |
|
|
2019
Q1 | $74M | Sell |
331,063
-18,582
| -5% | -$3.84M | 0.02% | 772 |
|
|
2018
Q4 | $65M | Sell |
349,645
-29,657
| -8% | -$6.08M | 0.02% | 794 |
|
|
2018
Q3 | $94.7M | Buy |
379,302
+41,716
| +12% | +$10.1M | 0.02% | 718 |
|
|
2018
Q2 | $73.6M | Buy |
337,586
+67,730
| +25% | +$14M | 0.02% | 775 |
|
|
2018
Q1 | $51.6M | Sell |
269,856
-48,103
| -15% | -$8.88M | 0.01% | 921 |
|
|
2017
Q4 | $49.7M | Sell |
317,959
-227,752
| -42% | -$35.8M | 0.01% | 985 |
|
|
2017
Q3 | $84.2M | Sell |
545,711
-131,796
| -19% | -$20.8M | 0.02% | 692 |
|
|
2017
Q2 | $109M | Sell |
677,507
-359,560
| -35% | -$58.4M | 0.03% | 590 |
|
|
2017
Q1 | $160M | Sell |
1,037,067
-304,479
| -23% | -$42M | 0.04% | 464 |
|
|
2016
Q4 | $157M | Buy |
1,341,546
+123,866
| +10% | +$14.1M | 0.04% | 444 |
|
|
2016
Q3 | $137M | Sell |
1,217,680
-99,466
| -8% | -$10.5M | 0.03% | 467 |
|
|
2016
Q2 | $122M | Buy |
1,317,146
+81,117
| +7% | +$6.97M | 0.03% | 506 |
|
|
2016
Q1 | $96.8M | Buy |
1,236,029
+13,780
| +1% | +$992K | 0.02% | 554 |
|
|
2015
Q4 | $89.1M | Sell |
1,222,249
-80,940
| -6% | -$5.77M | 0.02% | 594 |
|
|
2015
Q3 | $96.8M | Sell |
1,303,189
-13,874
| -1% | -$994K | 0.03% | 552 |
|
|
2015
Q2 | $84.5M | Buy |
1,317,063
+18,339
| +1% | +$1.27M | 0.02% | 669 |
|
|
2015
Q1 | $100M | Sell |
1,298,724
-87,214
| -6% | -$6.79M | 0.02% | 630 |
|
|
2014
Q4 | $103M | Sell |
1,385,938
-295,310
| -18% | -$20.7M | 0.02% | 628 |
|
|
2014
Q3 | $99M | Sell |
1,681,248
-185,472
| -10% | -$11.7M | 0.02% | 618 |
|
|
2014
Q2 | $125M | Buy |
1,866,720
+77,150
| +4% | +$4.91M | 0.03% | 501 |
|
|
2014
Q1 | $109M | Buy |
1,789,570
+48,834
| +3% | +$2.91M | 0.03% | 521 |
|
|
2013
Q4 | $92.6M | Buy |
1,740,736
+30,888
| +2% | +$1.63M | 0.03% | 557 |
|
|
2013
Q3 | $85.2M | Buy |
1,709,848
+73,200
| +4% | +$3.52M | 0.03% | 592 |
|
|
2013
Q2 | $73.4M | Buy |
+1,636,648
| New | +$71.5M | 0.02% | 613 |
|
Other funds holding IDXX
JP Morgan Chase's IDXX Position: Q2 2026 in Review
JP Morgan Chase reduced its Idexx Laboratories (IDXX) stake by 3.1% in Q2 2026, selling an estimated $13.5M and leaving 755,791 shares worth $405M. The position accounts for 0.02% of the portfolio, ranked #515.
JP Morgan Chase first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $556M in Q3 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- JP Morgan Chase held 755,791 shares of Idexx Laboratories worth $405M as of Q2 2026.
- JP Morgan Chase sold 24,091 Idexx Laboratories shares in Q2 2026, an estimated $13.5M.
- Idexx Laboratories made up 0.02% of JP Morgan Chase's portfolio in Q2 2026, its #515 holding.
- JP Morgan Chase first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
- JP Morgan Chase's Idexx Laboratories position peaked at $556M in Q3 2025.
- 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.